Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre.-MedSci.cn

Rates of trastuzumab-associated cardiotoxicity in patients with HER2-positive breast cancer at a tertiary cancer centre.

Tyagi, NK; Arora, R; Partridge, A; Tharmabala, M; Mukherjee, S; Leong, D; Dhesy-Thind, SK

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务